Teleflex Incorporated (NYSE:TFX) Shares Acquired by JPMorgan Chase & Co.

JPMorgan Chase & Co. boosted its position in Teleflex Incorporated (NYSE:TFX - Free Report) by 14.3% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 155,158 shares of the medical technology company's stock after buying an additional 19,466 shares during the period. JPMorgan Chase & Co. owned approximately 0.33% of Teleflex worth $38,374,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Cromwell Holdings LLC boosted its holdings in shares of Teleflex by 59.0% in the 3rd quarter. Cromwell Holdings LLC now owns 132 shares of the medical technology company's stock valued at $33,000 after acquiring an additional 49 shares during the last quarter. Avior Wealth Management LLC boosted its holdings in Teleflex by 190.6% in the third quarter. Avior Wealth Management LLC now owns 154 shares of the medical technology company's stock valued at $38,000 after purchasing an additional 101 shares during the last quarter. Ashton Thomas Securities LLC acquired a new stake in Teleflex during the 3rd quarter worth about $40,000. True Wealth Design LLC raised its stake in shares of Teleflex by 16,600.0% during the 3rd quarter. True Wealth Design LLC now owns 167 shares of the medical technology company's stock valued at $41,000 after buying an additional 166 shares during the last quarter. Finally, Canada Pension Plan Investment Board acquired a new position in shares of Teleflex in the 2nd quarter valued at about $42,000. Institutional investors and hedge funds own 95.62% of the company's stock.

Wall Street Analyst Weigh In

TFX has been the subject of several recent research reports. StockNews.com raised shares of Teleflex from a "hold" rating to a "buy" rating in a report on Thursday, November 28th. Truist Financial reduced their price target on Teleflex from $227.00 to $200.00 and set a "hold" rating for the company in a report on Wednesday, December 18th. Royal Bank of Canada lowered their price target on Teleflex from $275.00 to $245.00 and set an "outperform" rating on the stock in a research report on Friday, November 1st. Needham & Company LLC restated a "hold" rating on shares of Teleflex in a research report on Monday, December 16th. Finally, Mizuho decreased their target price on Teleflex from $275.00 to $250.00 and set a "neutral" rating on the stock in a research report on Friday, November 1st. Three investment analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $252.50.

Teleflex Price Performance

Shares of TFX traded down $1.54 during trading hours on Monday, hitting $180.21. 496,991 shares of the stock were exchanged, compared to its average volume of 434,197. The stock's 50-day moving average price is $190.92 and its two-hundred day moving average price is $217.38. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. The company has a market cap of $8.37 billion, a price-to-earnings ratio of 35.83, a price-to-earnings-growth ratio of 1.84 and a beta of 1.16. Teleflex Incorporated has a 12-month low of $171.69 and a 12-month high of $256.85.

Teleflex (NYSE:TFX - Get Free Report) last issued its earnings results on Thursday, October 31st. The medical technology company reported $3.49 EPS for the quarter, beating analysts' consensus estimates of $3.38 by $0.11. The business had revenue of $764.40 million during the quarter, compared to analysts' expectations of $768.68 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The company's quarterly revenue was up 2.4% compared to the same quarter last year. During the same period in the prior year, the business earned $3.64 earnings per share. Research analysts expect that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, December 16th. Investors of record on Friday, November 15th were given a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 0.75%. The ex-dividend date of this dividend was Friday, November 15th. Teleflex's dividend payout ratio (DPR) is presently 27.04%.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.